SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-015174
Filing Date
2022-04-20
Accepted
2022-04-20 16:12:46
Documents
4
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20003233x1_def14a.htm DEF 14A 590159
2 ny20003233x1_pc1.jpg GRAPHIC 505710
3 ny20003233x1_pc2.jpg GRAPHIC 374072
4 sig_etengelsonx1.jpg GRAPHIC 12187
  Complete submission text file 0001140361-22-015174.txt   1818847
Mailing Address 1412 62ND STREET EMERYVILLE CA 94608
Business Address 1412 62ND STREET EMERYVILLE CA 94608 (814) 574-1546
Lucira Health, Inc. (Filer) CIK: 0001652724 (see all company filings)

IRS No.: 272491037 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39976 | Film No.: 22838160
SIC: 2835 In Vitro & In Vivo Diagnostic Substances